The Claim
Tubuloside B, derived from Cistanche tubulosa, inhibits the binding of bacterial LPDP to human PDLIM3 in mice and reduces the severity of colitis induced by Staphylococcus lentus.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Tubuloside B, a compound from the herb Cistanche tubulosa, prevents a specific bacterial protein from binding to a human protein in mice, resulting in less severe colon inflammation caused by Staphylococcus lentus.
See the scientific wording
Tubuloside B, a compound derived from the traditional Chinese herb Cistanche tubulosa, blocks the interaction between the bacterial protein LPDP and human PDLIM3 in mice, and reduces colitis severity worsened by Staphylococcus lentus, suggesting a potential therapeutic strategy for microbiota-driven inflammation.
A bacterial protein called LPDP sticks to a human protein called PDLIM3 in the gut lining, which turns on a danger signal that makes the gut produce inflammatory chemicals. These chemicals damage the gut barrier and cause swelling. Tubuloside B stops LPDP from sticking to PDLIM3, which shuts down the danger signal, reduces inflammation, and protects the gut lining.
What the research says
1 studyA natural compound called tubuloside B, from a traditional herb, was shown in mice to stop a harmful handshake between a gut bacterium and a human protein, which reduces gut inflammation. This suggests it could one day help treat bowel diseases like IBD.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.